483
In2Bones, SASIn2Bones, SAS – FDA 483, Oct 27, 2016
Record Details
An FDA inspection of In2Bones, SAS, a device manufacturer in Ecully, France, identified one observation related to quality system deficiencies. The firm's procedures for supplier control were found to be inadequately defined, specifically regarding follow-up actions based on supplier evaluations. This indicates a moderate severity issue concerning quality management system oversight.
View Company Profile
ID · a123d587-df8c-425e-b5b8-dc6ff8cad112
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.